Loading…

Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death

The efficacy of methotrexate (MTX), a widely used cytotoxic chemotherapeutic agent, is often limited by severe side effects and toxic sequelae. Regarding the mechanisms of these side effects, several hypotheses have been put forward, among which oxidative stress is noticeable. The present study was...

Full description

Saved in:
Bibliographic Details
Published in:Toxicology and applied pharmacology 2005-11, Vol.209 (1), p.39-50
Main Authors: Çetiner, Mustafa, Şener, Göksel, Şehirli, A. Özer, Ekşioğlu-Demiralp, Emel, Ercan, Feriha, Şirvancı, Serap, Gedik, Nursal, Akpulat, Sertaç, Tecimer, Tülay, Yeğen, Berrak Ç.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The efficacy of methotrexate (MTX), a widely used cytotoxic chemotherapeutic agent, is often limited by severe side effects and toxic sequelae. Regarding the mechanisms of these side effects, several hypotheses have been put forward, among which oxidative stress is noticeable. The present study was undertaken to determine whether taurine, a potent free radical scavenger, could ameliorate MTX-induced oxidative injury and modulate immune response. Following a single dose of methotrexate (20 mg/kg), either saline or taurine (50 mg/kg) was administered for 5 days. After decapitation of the rats, trunk blood was obtained and the ileum, liver, and kidney were removed to measure malondialdehyde (MDA) and glutathione (GSH) levels, myeloperoxidase (MPO) activity, and collagen content, as well as histological examination. Our results showed that MTX administration increased the MDA, MPO activity, and collagen contents and decreased GSH levels in all tissues ( P 
ISSN:0041-008X
1096-0333
DOI:10.1016/j.taap.2005.03.009